Cerecor Inc

NASDAQ:CERC  
2.73
-0.03 (-1.09%)
Products

Cerecor Announces FDA Acceptance Of Investigational New Drug Application For CERC-007 For Treatment Of Relapsed Or Refractory Multiple Myeloma

Published: 12/08/2020 12:27 GMT
Cerecor Inc (CERC) - Cerecor Announces FDA Acceptance of Investigational New Drug Application for Cerc-007 for Treatment of Relapsed Or Refractory Multiple Myeloma.
Cerecor Inc - Initial Data is Expected in Q1 of 2021.